Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
Hanquet, G., van Damme, P., Brasseur, D., de Cuyper, X., Gregor, S., Holmberg, M., Martin, R., Molnar, Z., Pompa, M.G., Snacken, R., van der Se, M., van Ranst, M., Wirtz, A., Neels, P.
Modelling the risk-benefit impact of H1N1 influenza vaccines
Phillips, L.D., Fasolo, B., Zafiropoulous, N., Eichler, H.G., Ehmann, F., Jekerle, V., Kramarz, P., Nicoll, A., Lönngren, T.
Overview Of Pandemic Influenza A(h1n1) 2009 Vaccination In Europe. Preliminary Results Of Survey Conducted By Venice, 2010Archived
Mereckiene, J., Cotter, S., Weber, T., D'Ancona, F., Nicoll, A., Lopalco, P., Giambi, C., Levy-Bruhl, D., Johansen, K., Dematte, L., Salmaso, S., Stefanoff, P., Greco, D., Polkowska, A., O'Flanagan, D.
Moderate pandemic, not many dead - Learning the right lessons in Europe from the 2009 pandemic
Nicoll, A., McKee, M.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of IrelandArchived
Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.